CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Characteristics of HBeAg-positive patients chronically infectedwith hepatitis b virus (HBV) who achieved hbsag loss/seroconversion following tenofovir disoproxil fumarate (TDF) treatment
DOI 10.1055/s-0029-1241404
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Petersen, M Manns, S Mauss, S Zeuzem, G Teuber, B Möller, J Heathcote, P Marcellin, J Sorbel, F Rousseau
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: HBsAg loss was observed in significantly more TDF-treated patients versus adefovir dipivoxil (ADV) at Week (W) 48 in HBeAg-positive patients enrolled in the pivotal, phase 3 study 103 (3.2% TDF versus 0% ADV; p=0.02). Goal: To characterize the TDF-treated patients who achieved HBsAg loss by W96 in study 103. Methods: Patients with HBeAg-positive chronic hepatitis B (CHB) were randomized to double-blind, once d…
Zitieren
Zitierempfehlung
J Petersen, M Manns, S Mauss, S Zeuzem, G Teuber, B Möller, J Heathcote, P Marcellin, J Sorbel, F Rousseau (2009) Characteristics of HBeAg-positive patients chronically infectedwith hepatitis b virus (HBV) who achieved hbsag loss/seroconversion following tenofovir disoproxil fumarate (TDF) treatment. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0029-1241404
Mit CareLit weiterarbeiten